J&J-Intra-Cellular deal receives US green light
MLex Summary: Johnson & Johnson and Intra-Cellular Therapies have received clearance from the US competition authorities for their proposed $14.6 billion transaction, according to a filing with the US Securities and...To view the full article, register now.
Already a subscriber? Click here to view full article